Dettenheim, Germany

Alexandra Matzke

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Pforzheim, DE (2015)
  • Dettenheim, DE (2014 - 2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Alexandra Matzke: Innovator in Cancer Treatment

Introduction

Alexandra Matzke is a prominent inventor based in Dettenheim, Germany. She has made significant contributions to the field of cancer treatment, particularly in developing innovative peptides for combating pancreatic cancer. With a total of 5 patents to her name, Matzke's work is paving the way for new therapeutic approaches.

Latest Patents

Matzke's latest patents include groundbreaking inventions such as "CD44v6-derived peptides for treating metastasizing cancer." This invention relates to compounds, pharmaceutical compositions, and methods for treating various forms of pancreatic cancer. Another notable patent is "CD44v6-derived peptides for treating pancreatic cancer," which also focuses on compounds and methods aimed at addressing this challenging disease.

Career Highlights

Throughout her career, Matzke has worked with notable organizations, including Amcure GmbH and the Karlsruhe Institute of Technology. Her research and innovations have garnered attention in the scientific community, contributing to advancements in cancer therapies.

Collaborations

Matzke has collaborated with esteemed colleagues such as Helmut Ponta and Veronique Orian-Rousseau. These partnerships have enhanced her research efforts and expanded the impact of her work in the field of oncology.

Conclusion

Alexandra Matzke's contributions to cancer treatment through her innovative patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in therapeutic strategies for pancreatic cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…